2024년에 101억 달러로 추정되는 세계의 하이브리드 이미징 시장은 2024-2030년에 CAGR 4.9%로 성장하며, 2030년에는 134억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 PET/CT 시스템은 CAGR 4.9%를 기록하며, 분석 기간 종료시에는 47억 달러에 달할 것으로 예측됩니다. SPET/CT 시스템 분야의 성장률은 분석 기간에 CAGR 5.5%로 추정됩니다.
미국 시장은 28억 달러, 중국은 CAGR 4.7%로 성장 예측
미국의 하이브리드 이미징 시장은 2024년에 28억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 21억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 4.7%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.5%와 4.1%로 예측됩니다. 유럽에서는 독일이 CAGR 4.8%로 성장할 것으로 예측됩니다.
세계의 하이브리드 이미징 시장 - 주요 동향과 촉진요인 정리
하이브리드 이미징이 의료 진단에 혁명을 일으킬 수 있는 이유는 무엇인가?
하이브리드 이미징은 양전자방사선단층촬영(PET), 자기공명영상(MRI) 등 두 가지 이상의 영상 양식을 결합하여 보다 종합적인 진단 정보를 제공함으로써 의료 진단의 큰 진보를 상징합니다. 이러한 하이브리드 시스템은 한 번의 스캔으로 기능적 데이터와 해부학적 데이터를 모두 제공함으로써 질병의 감지, 진단 및 모니터링 능력을 향상시킵니다. 예를 들어 PET-MRI는 암, 신경질환, 심혈관 질환의 발견에 필수적인 우수한 연조직 대비와 기능적 영상을 제공합니다. 다양한 영상 기술을 통합하여 보다 정확한 진단, 치료 계획 개선, 환자 예후 개선이 가능하여 하이브리드 이미징은 현대 의료에 없어서는 안 될 툴이 되었습니다.
기술의 발전은 하이브리드 이미징 시장을 어떻게 형성하고 있는가?
기술 혁신은 하이브리드 이미징 시스템의 발전에 있으며, 매우 중요한 역할을 하고 있습니다. 검출기 기술, 영상 재구성 알고리즘, 데이터 처리의 발전으로 하이브리드 이미징 장비의 정확도와 속도가 향상되고 있습니다. 예를 들어 디지털 검출기의 개발로 PET-CT와 SPECT-CT 시스템의 감도와 해상도가 향상되어 보다 선명한 영상과 질병을 조기에 발견할 수 있게 되었습니다. 또한 AI를 활용한 영상 분석 툴이 하이브리드 이미징의 워크플로우에 통합되어 보다 빠른 해석과 진단 정확도 향상을 가능하게 하고 있습니다. 또한 하이브리드 이미징 시스템은 보다 컴팩트하고 접근성이 높아져 외래 진료소 및 소규모 의료시설에서 사용이 확대되고 있으며, 시장 저변이 확대되고 있습니다.
시장 세분화는 하이브리드 이미징 시장 성장에 어떤 영향을 미치는가?
PET-CT, PET-MRI, SPECT-CT가 있으며, PET-CT는 종양 검출 및 치료 모니터링을 위해 종양학에서 널리 사용되고 있으며, 가장 큰 시장 점유율을 차지하고 있습니다. 하이브리드 이미징의 용도는 종양학, 신경학, 심장학, 정형외과 등 다양하지만, 전 세계 암 발병률 증가로 인해 종양학이 주요 용도로 부상하고 있습니다. 최종사용자에는 병원, 영상 진단센터, 연구기관이 포함되며, 병원은 첨단 영상 진단 인프라를 갖추고 있으며, 가장 큰 시장 점유율을 차지하고 있습니다. 또한 하이브리드 이미징이 치료 효과를 평가하고 치료 접근법을 맞춤화하는 데 사용되는 맞춤형 의료 용도도 성장하고 있습니다.
하이브리드 이미징 시장의 성장을 가속하는 요인은 무엇인가?
하이브리드 이미징 시장의 성장은 만성질환의 유병률 증가, 영상 진단 기술의 발전, 조기 진단 및 정확한 진단에 대한 수요 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 암, 심혈관 질환, 신경계 질환이 전 세계에서 증가하는 가운데, 의료 서비스 프로바이더들은 진단 정확도를 높이고 치료 방침을 결정하기 위해 하이브리드 이미징을 활용하고 있습니다. 영상 처리에서 AI와 머신러닝의 통합은 하이브리드 이미징 시스템의 정확성과 효율성을 향상시켜 임상 현장에서의 가치를 높이고 있습니다. 또한 맞춤형 의료의 확산과 개발도상국의 의료 인프라 확대가 하이브리드 이미징 기술에 대한 수요를 촉진하고 있습니다.
부문
유형(PET/CT 시스템, SPET/CT 시스템, PET/MR시스템, OCT/안저 이미징 시스템, 기타 유형), 용도(종양학, 안과, 순환기학, 뇌·신경학, 기타 용도), 최종 용도(병원, 영상 진단 센터, 기타 최종 용도)
조사 대상 기업의 예
Bruker
Canon Medical Systems Corp.
Cubresa, Inc.
Fujifilm VisualSonics, Inc.
GE Healthcare
Koninklijke Philips N.V.
Mediso Ltd.
MILabs B.V.
MR Solutions
PerkinElmer, Inc.
Siemens Healthineers
TriFoil Imaging
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Hybrid Imaging Market to Reach US$13.4 Billion by 2030
The global market for Hybrid Imaging estimated at US$10.1 Billion in the year 2024, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the SPET / CT Systems segment is estimated at 5.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 4.7% CAGR
The Hybrid Imaging market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Global Hybrid Imaging Market - Key Trends and Drivers Summarized
Why Is Hybrid Imaging Revolutionizing Medical Diagnostics?
Hybrid imaging represents a significant advancement in medical diagnostics by combining two or more imaging modalities, such as Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI), to provide more comprehensive diagnostic information. These hybrid systems enhance the ability to detect, diagnose, and monitor diseases by offering both functional and anatomical data in a single scan. For instance, PET-MRI provides superior soft-tissue contrast and functional imaging, which is critical for detecting cancer, neurological disorders, and cardiovascular diseases. The integration of different imaging technologies allows for more accurate diagnoses, improved treatment planning, and better patient outcomes, making hybrid imaging an indispensable tool in modern healthcare.
How Are Technological Advancements Shaping the Hybrid Imaging Market?
Technological innovations are playing a pivotal role in the evolution of hybrid imaging systems. Advances in detector technologies, image reconstruction algorithms, and data processing have improved the precision and speed of hybrid imaging devices. For example, the development of digital detectors has enhanced the sensitivity and resolution of PET-CT and SPECT-CT systems, leading to sharper images and earlier disease detection. Moreover, AI-driven image analysis tools are increasingly being integrated into hybrid imaging workflows, allowing for faster interpretation and improved diagnostic accuracy. Hybrid imaging systems are also becoming more compact and accessible, which is expanding their use in outpatient clinics and smaller healthcare facilities, broadening the market's reach.
How Do Market Segments Influence the Growth of the Hybrid Imaging Market?
Modalities include PET-CT, PET-MRI, and SPECT-CT, with PET-CT holding the largest market share due to its widespread use in oncology for tumor detection and treatment monitoring. Applications of hybrid imaging span across oncology, neurology, cardiology, and orthopedics, with oncology being the dominant application area due to the increasing global burden of cancer. End-users include hospitals, diagnostic imaging centers, and research institutions, with hospitals accounting for the largest market share because of their advanced imaging infrastructure. The market is also witnessing growth in personalized medicine applications, where hybrid imaging is used to assess treatment efficacy and tailor therapeutic approaches.
What Factors Are Driving the Growth in the Hybrid Imaging Market?
The growth in the hybrid imaging market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing demand for early and accurate diagnosis. As the global burden of cancer, cardiovascular diseases, and neurological disorders continues to rise, healthcare providers are increasingly relying on hybrid imaging to improve diagnostic precision and guide treatment decisions. The integration of AI and machine learning in image processing is enhancing the accuracy and efficiency of hybrid imaging systems, making them more valuable in clinical settings. Additionally, the growing adoption of personalized medicine and the expansion of healthcare infrastructure in developing regions are fueling the demand for hybrid imaging technologies.
SCOPE OF STUDY:
The report analyzes the Hybrid Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System, Other Types); Application (Oncology, Ophthalmology, Cardiology, Brain & Neurology, Other Applications); End-Use (Hospitals, Diagnostic Imaging Centers, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 36 Featured) -
Bruker
Canon Medical Systems Corp.
Cubresa, Inc.
Fujifilm VisualSonics, Inc.
GE Healthcare
Koninklijke Philips N.V.
Mediso Ltd.
MILabs B.V.
MR Solutions
PerkinElmer, Inc.
Siemens Healthineers
TriFoil Imaging
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Global Economic Update
Hybrid Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Multi-Modal Imaging in Diagnostics Propels Growth in Hybrid Imaging
Technological Advancements in PET-CT and SPECT-CT Strengthen the Business Case for Hybrid Imaging
Increasing Adoption of Hybrid Imaging in Oncology and Cardiology Expands Addressable Market
Growing Focus on Early Disease Detection and Precision Medicine Drives Demand for Hybrid Imaging Systems
Government Initiatives to Improve Healthcare Infrastructure Spur Market Adoption of Hybrid Imaging
Rising Interest in Personalized and Non-Invasive Diagnostic Solutions Fuels Hybrid Imaging Demand
Expansion of Hybrid Imaging Applications in Neurology and Orthopedics Creates New Market Opportunities
Integration of AI and Machine Learning in Hybrid Imaging Accelerates Market Innovation
Growing Focus on Reducing Diagnostic Errors Strengthens the Case for Hybrid Imaging
Rising Prevalence of Chronic Diseases and Aging Population Drives Demand for Hybrid Imaging Solutions
Increasing Adoption of Mobile and Portable Hybrid Imaging Devices Creates New Opportunities
Technological Innovations in Image Fusion and Resolution Enhance the Efficiency of Hybrid Imaging Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Hybrid Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 12: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 14: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 15: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 18: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 20: World Historic Review for Brain & Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 21: World 15-Year Perspective for Brain & Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 26: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 27: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 30: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 31: World Hybrid Imaging Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 32: World Recent Past, Current & Future Analysis for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for PET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for PET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for SPET / CT Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for SPET / CT Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for PET / MR Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for PET / MR Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for OCT / Fundus Imaging System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for OCT / Fundus Imaging System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 53: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 62: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 71: China Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 80: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Hybrid Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Europe 15-Year Perspective for Hybrid Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 92: France Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: France 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 95: France Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: France Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: France 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 101: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Germany 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 104: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Germany 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Germany 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 110: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Italy 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 113: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Italy 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Italy 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 119: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: UK 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 122: UK Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: UK Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: UK 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: UK Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: UK 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Rest of Europe 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Rest of Europe 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Rest of Europe 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Hybrid Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Asia-Pacific 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Asia-Pacific 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Hybrid Imaging by Type - PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Rest of World 15-Year Perspective for Hybrid Imaging by Type - Percentage Breakdown of Value Sales for PET / CT Systems, SPET / CT Systems, PET / MR Systems, OCT / Fundus Imaging System and Other Types for the Years 2015, 2025 & 2030
TABLE 149: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Rest of World Historic Review for Hybrid Imaging by Application - Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Rest of World 15-Year Perspective for Hybrid Imaging by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Ophthalmology, Cardiology and Brain & Neurology for the Years 2015, 2025 & 2030
TABLE 152: Rest of World Recent Past, Current & Future Analysis for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of World Historic Review for Hybrid Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of World 15-Year Perspective for Hybrid Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2015, 2025 & 2030
